http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018111004-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f905833d54aa40b7cbaaa79281ef40a0 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0626 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0651 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0659 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-037 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate | 2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eb1ba83cdc51fe2a0d3f29d291a97bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2366d90ffee43c55b284bf7f33fdecf7 |
| publicationDate | 2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2018111004-A1 |
| titleOfInvention | Novel treatment methodologies using light therapy |
| abstract | A treatment method using a novel combination of non-invasive near infrared light (NIR)/laser therapy and the pharmacological agent ketamine, to more efficaciously upregulate neurotrophins and improve mitochondrial function. The NIR therapy is characterized by wavelengths of 200-2000 nm at surface wattage of 0.01-50.00 watts delivered by stationary emitters. The method can employ active circular motion techniques which involve moving the infrared light applicator manually, and/or by computer-controlled apparatus, conducted in conjunction with ketamine pharmacological therapy. In addition, a novel method of targeting NIR treatment of and characterizing central nervous system disorders using SPECT functional neuroimaging followed by quantitative analysis and a novel method of targeting NIR treatment of and characterizing spinal cord or nerve-related disorders using neurophysiological testing followed by quantitative analysis. Also, a novel method of using serial SPECT neuroimaging with quantitative analysis or using serial neurophysiological testing followed by quantitative analysis to elucidate changes in response to treatment. |
| priorityDate | 2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 489.